Biosense Webster launches AF (atrial flutter) ablation catheter
This article was originally published in Clinica
Executive Summary
Biosense Webster has launched for sale in the US what it claims is the first FDA-cleared dual sensor 8mm tip ablation catheter for treating atrial flutter (AF). The Navistar DS catheter, which showed clinical efficacy in the acute and six-month follow-up settings of 98.8% and 96.7%, provides benefits over conventional 4mm catheters, says the firm.